Pieris Pharmaceuticals Announces Oral Presentation of Phase 1 Data for 4-1BB/HER2 Bispecific PRS-343 at European Society for Medical Oncology (ESMO) Virtual Congress 2020
BOSTON, MA / ACCESSWIRE / July 23, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage…
Wintermar Offshore (WINS:JK) Reports 9M2025 Results
Star Plus Legend (6683.HK) Becomes a Strategic Shareholder of Galaxy
Geekvape SOUL II Wins 2025 MUSE Gold Award – A Testament to Strength and Innovation
AI Pets Platform FurGPT Prepares to List FGPT Token on Binance Exchange and Aster DEX
Beyond Music, Beyond Worlds – X:THELABEL Rewrites the Rules of Virtual K-Pop